Former J&J exec joins Stentys
This article was originally published in Clinica
Stentys, a specialist in stents for complex blocked coronary arteries, has appointed Paul Geudens as vice-president of sales and marketing. Mr Geudens joins the Princeton, New Jersey-based company from Johnson & Johnson's cardiovascular subsidiary Cordis, where he spent the last 11 years. He was most recently director of marketing for peripheral and neurovascular products and has extensive experience in launching new products. At Stentys, Mr Geudens will be leading the commercialisation of the firm's recently CE-marked disconnectable and self-expanding stent for treating acute myocardial infarction and coronary artery bifurcations.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.